Esperion Therapeutics. ETC-1002

3 Little-Known Biotechs Working On Potential Blockbusters
Motley Fool
Sun, 03/29/15 - 11:42 am
Ophthotech
Fovista
Esperion Therapeutics. ETC-1002
Prothena
PRX-002